Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combination Therapy of Resilience Intervention With Biologics in Crohn's Disease (CATHARSIS Trial)

NCT06512597 is registered in ClinicalTrials.gov with Icahn School of Medicine at Mount Sinai as lead sponsor.

NCT NCT06512597
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06512597 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combination Therapy of Resilience Intervention With Biologics in Crohn's Disease (CATHARSIS Trial)
Lead sponsor
Icahn School of Medicine at Mount Sinai
Phase
Not applicable
Overall status
Recruiting
Start date
November 1, 2024
Completion date
July 30, 2028
Enrollment
170 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease